TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vaccindirekt i Sverige AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
494,172
|
420,047
|
311,376 |
| Financial expenses |
302
|
128
|
131 |
| Earnings before taxes |
64,117
|
81,501
|
66,606 |
| EBITDA |
62,750
|
83,987
|
69,832 |
| Total assets |
179,156
|
176,388
|
100,566 |
| Current assets |
56,449
|
67,160
|
81,078 |
| Current liabilities |
60,324
|
59,790
|
41,222 |
| Equity capital |
109,516
|
107,381
|
55,184 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
181
|
188
|
163 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
61.1%
|
60.9%
|
54.9% |
| Turnover per employee |
2,730
|
2,234
|
1,910 |
| Profit as a percentage of turnover |
13.0%
|
19.4%
|
21.4% |
| Return on assets (ROA) |
36.0%
|
46.3%
|
66.4% |
| Current ratio |
93.6%
|
112.3%
|
196.7% |
| Return on equity (ROE) |
58.5%
|
75.9%
|
120.7% |
| Change turnover |
66,552
|
86,577
|
82,534 |
| Change turnover % |
16%
|
26%
|
36% |
| Chg. No. of employees |
-7
|
25
|
-3 |
| Chg. No. of employees % |
-4%
|
15%
|
-2% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.